Cannabis Science, Inc. (OTCBB: GFON), or Gulf Onshore, Inc. (GFON), is yet another public stock company which is going after the field of legalized medical marijuana. Just last week the company was called Gulf Onshore and it just changed its name to Cannabis Science, Inc. after acquiring the assets of Cannex Therapeutics LLC about 10 days ago. Last week the company also announced that it had selected its first pharmaceutical cannabis product for FDA testing. It was not even two weeks ago that a company called Medical Marijuana, Inc. (OTC: CVIV) had pursued a similar strategy in coming public after formerly being called Club Vivanet.
This new company’s description says that it is at the forefront of medical marijuana research and development, and the company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. The company is dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
This morning we saw a headline that the company had announced its 420 Commemorative Certificate Program and that it has engaged Capital Structure Today to provide it with branding and public/investor awareness services. In short, you can probably expect to hear more about this company in the form of headlines and news stories.
When we ran the piece about Medical Marijuana, Inc. (OTC: CVIV), we noted, “If you ever thought that cannabis, pot, weed, or hemp were not going to be applied to a public company, it looks like that has changed.” The fact that a second company is now technically public in the field in not even two weeks is just sort of a head scratcher.
This almost seems like something we’d expect to read in THE ONION, but this now has a real company and it is actually a stock if you count Pink Sheet and OTC stocks as full public companies. Sometimes the real news is almost more unbelievable than the made-up news.
Whether or not these companies take off is something we won’t speculate on. As we have noted before, there have been stranger things yet.
JON C. OGG